147 related articles for article (PubMed ID: 30171833)
1. DUSP5 expression associates with poor prognosis in human neuroblastoma.
Aurtenetxe O; Zaldumbide L; Erramuzpe A; López R; López JI; Cortés JM; Pulido R; Nunes-Xavier CE
Exp Mol Pathol; 2018 Dec; 105(3):272-278. PubMed ID: 30171833
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine phosphatase PTPN1 modulates cell growth and associates with poor outcome in human neuroblastoma.
Nunes-Xavier CE; Aurtenetxe O; Zaldumbide L; López-Almaraz R; Erramuzpe A; Cortés JM; López JI; Pulido R
Diagn Pathol; 2019 Dec; 14(1):134. PubMed ID: 31837707
[TBL] [Abstract][Full Text] [Related]
3. Dual-Specificity Phosphatases in Neuroblastoma Cell Growth and Differentiation.
Nunes-Xavier CE; Zaldumbide L; Aurtenetxe O; López-Almaraz R; López JI; Pulido R
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866462
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
[TBL] [Abstract][Full Text] [Related]
5. Identification of DDX39A as a Potential Biomarker for Unfavorable Neuroblastoma Using a Proteomic Approach.
Otake K; Uchida K; Ide S; Kobayashi Y; Kobayashi I; Kusunoki M
Pediatr Blood Cancer; 2016 Feb; 63(2):221-7. PubMed ID: 26469522
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
[TBL] [Abstract][Full Text] [Related]
7. Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
Sheikh A; Takatori A; Hossain MS; Hasan MK; Tagawa M; Nagase H; Nakagawara A
Cancer Sci; 2016 Sep; 107(9):1223-32. PubMed ID: 27357360
[TBL] [Abstract][Full Text] [Related]
8. The combined effect of retinoic acid and LSD1 siRNA inhibition on cell death in the human neuroblastoma cell line SH-SY5Y.
Xu G; Xiao Y; Hu J; Xing L; Zhao O; Wu Y
Cell Physiol Biochem; 2013; 31(6):854-62. PubMed ID: 23816987
[TBL] [Abstract][Full Text] [Related]
9. Expression of promyelocytic leukemia protein increases during the differentiation of human neuroblastoma cells.
Yu E; Choi EK; Kim CJ
Virchows Arch; 2003 Mar; 442(3):278-83. PubMed ID: 12647219
[TBL] [Abstract][Full Text] [Related]
10. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
[TBL] [Abstract][Full Text] [Related]
11. Differential up-regulation of MAP kinase phosphatases MKP3/DUSP6 and DUSP5 by Ets2 and c-Jun converge in the control of the growth arrest versus proliferation response of MCF-7 breast cancer cells to phorbol ester.
Nunes-Xavier CE; Tárrega C; Cejudo-Marín R; Frijhoff J; Sandin A; Ostman A; Pulido R
J Biol Chem; 2010 Aug; 285(34):26417-30. PubMed ID: 20554528
[TBL] [Abstract][Full Text] [Related]
12. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
13. FAK-Src-paxillin system expression and disease outcome in human neuroblastoma.
Kratimenos P; Koutroulis I; Syriopoulou V; Michailidi C; Delivoria-Papadopoulos M; Klijanienko J; Theocharis S
Pediatr Hematol Oncol; 2017 May; 34(4):221-230. PubMed ID: 29040002
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines.
Wang Z; Lei H; Sun Q
Oncol Rep; 2016 May; 35(5):2943-51. PubMed ID: 26936280
[TBL] [Abstract][Full Text] [Related]
16. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome.
Kim DK; Alvarado CS; Abramowsky CR; Gu L; Zhou M; Soe MM; Sullivan K; George B; Schemankewitz E; Findley HW
Pediatr Dev Pathol; 2005; 8(6):621-9. PubMed ID: 16328668
[TBL] [Abstract][Full Text] [Related]
17. B4GALNT3 expression predicts a favorable prognosis and suppresses cell migration and invasion via β₁ integrin signaling in neuroblastoma.
Hsu WM; Che MI; Liao YF; Chang HH; Chen CH; Huang YM; Jeng YM; Huang J; Quon MJ; Lee H; Huang HC; Huang MC
Am J Pathol; 2011 Sep; 179(3):1394-404. PubMed ID: 21741930
[TBL] [Abstract][Full Text] [Related]
18. β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma.
Chang HH; Chen CH; Chou CH; Liao YF; Huang MJ; Chen YH; Wang WJ; Huang J; Hung JS; Ho WL; Jeng YM; Che MI; Lee H; Lu MY; Yang YL; Jou ST; Lin DT; Lin KH; Hsu WM; Huang MC
Clin Cancer Res; 2013 Apr; 19(7):1705-16. PubMed ID: 23444218
[TBL] [Abstract][Full Text] [Related]
19. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
Matsumoto K; Wada RK; Yamashiro JM; Kaplan DR; Thiele CJ
Cancer Res; 1995 Apr; 55(8):1798-806. PubMed ID: 7712490
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-like 1 is involved in the growth and metastasis of neuroblastoma cells.
Wen M; Wang H; Zhang X; Long J; Lv Z; Kong Q; An Y
Int J Oncol; 2012 Oct; 41(4):1419-24. PubMed ID: 22797702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
